How many drugs treat Osteomalacia?

Drug Landscape tracks 6 marketed treatments for Osteomalacia (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/osteomalacia.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-09 · How we verify

Osteomalacia — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Osteomalacia (disease) competitive landscape: 6 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

6 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Osteomalacia, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Crysvita	BUROSUMAB	Ultragenyx Pharm Inc		FGF23	2018-01-01
Infuvite Adult	Colecalciferol	Novartis	Vitamin D	Vitamin D3 receptor	2000-01-01
Drisdol	ERGOCALCIFEROL	Esjay Pharma	Provitamin D2 Compound [EPC]	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	1941-01-01
Hornel	FALECALCITRIOL	Taisho Pharmaceutical
CRYSVITA	BUROSUMAB-TWZA	KYOWA KIRIN		Fibroblast growth factor 23
Calciferol	Calciferol	Department of Medical Services Ministry of Public Health of Thailand		Vitamin D 25-hydroxylase, 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial, Vitamin D3 receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 1 drug in Osteomalacia
Department of Medical Services Ministry of Public Health of Thailand · 1 drug in Osteomalacia
Esjay Pharma · 1 drug in Osteomalacia
KYOWA KIRIN · 1 drug in Osteomalacia
Novartis · 1 drug in Osteomalacia
Taisho Pharmaceutical · 1 drug in Osteomalacia
Ultragenyx Pharm Inc · 1 drug in Osteomalacia

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Osteomalacia:

Cite this brief

Drug Landscape (2026). Osteomalacia — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/osteomalacia. Accessed 2026-06-09.

Osteomalacia full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing